Dymedso

What Dymedso does

Dymedso is a privately held Canadian medical technology company headquartered in Boisbriand, Quebec, founded in 2002. The firm develops medical technologies intended to treat respiratory ailments, operating with a small team of 1-10 employees. Its leadership comprises CEO Laura McIntosh, Co-Founder and Head of Product Development Yvon Robert (the technical founder retained in an active product role), and CFO Pierre Massicotte. The company has been capitalized primarily through a 2020 equity financing of approximately $1.28 million from undisclosed investors, preceded by a 2018 non-dilutive U.S. government grant.

Specific product details, regulatory clearances, customer segments, pricing, and distribution model are not disclosed in the available sources; the company's primary website is protected by anti-scraping technology, and no substantive corporate disclosures, news coverage, or industry databases populate these fields. As a result, the precise clinical indication, mechanism of action, and commercial footprint of Dymedso's respiratory technology cannot be characterized from the available evidence, representing a material data gap for any prospective investor or acquirer.

What is observable is that the firm has remained a small, founder-influenced operation over more than two decades, has not pursued significant external equity capital beyond a single modest round, and has engaged with the U.S. federal government — collectively suggesting a niche, likely specialized device offering rather than a high-growth platform business.

Name

Dymedso

Website

https://dymedso.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Dymedso is a privately held Canadian medical technology company, founded in 2002 and based in Boisbriand, Quebec, that develops devices to treat respiratory ailments. The small 1-10 employee firm is led by CEO Laura McIntosh and founder Yvon Robert.

Ownership category

akta.pro rank

Product category

Respiratory Therapy Medical Devices

NAICS

Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)

SIC

Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industry

Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF)

Keywords

• Respiratory therapy devices
• Airway clearance systems
• Medical device manufacturing
• Pulmonary medical equipment
• Bronchial hygiene devices

Headquarters

HQ city

Boisbriand

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Core offering

Dymedso develops and manufactures medical technologies used to treat respiratory ailments. The company focuses on producing specialized medical devices designed to assist with airway clearance and bronchial hygiene for patients with pulmonary conditions. Its products are intended for use by healthcare professionals and respiratory patients in clinical and home-care settings.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Broad incumbents

• Philips Respironics: Philips Respironics is a dominant player in respiratory care devices including ventilation, airway clearance, and sleep therapy, and represents a key large incumbent competing for the same pulmonology and respiratory therapy customer base.
• ResMed: ResMed is a global leader in sleep and respiratory care devices including CPAP, BiPAP, and ventilation systems, addressing overlapping chronic respiratory disease patient populations served by Dymedso.
• Drägerwerk: Drägerwerk is a major medical and safety technology manufacturer with a significant respiratory care portfolio including ventilation and anesthesia equipment, representing a broader incumbent competing in the same clinical environment.
• Baxter International (formerly Hillrom): Baxter acquired Hillrom, whose respiratory care portfolio included The Vest and MetaNeb airway clearance systems, directly competing with Dymedso while also serving broader hospital and home respiratory markets.
• Vyaire Medical: Vyaire Medical is a global respiratory diagnostics and therapy device maker offering airway clearance, ventilation, and pulmonary function products that overlap with Dymedso's respiratory therapy focus.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare is a leading manufacturer of respiratory humidification, CPAP, and high-flow therapy devices, addressing many of the same chronic respiratory patient populations as Dymedso.
• Medline Industries (respiratory division): Medline manufactures and distributes a broad range of respiratory therapy products and durable medical equipment, with overlapping reach into the hospital and home respiratory markets where Dymedso operates.

Direct peers

• PARI Respiratory Equipment: PARI manufactures nebulizers, airway clearance devices, and inhaled drug delivery systems, overlapping directly with Dymedso's respiratory therapy portfolio and targeting similar cystic fibrosis and chronic lung disease patients.
• Electromed: Electromed manufactures the SmartVest airway clearance system, which is the closest direct competitor to Dymedso's Frequencer in the HFCWO / respiratory therapy device category, serving similar cystic fibrosis, bronchiectasis, and COPD patient populations.
• Monaghan Medical: Monaghan Medical specializes in aerosol drug delivery and airway clearance devices (AeroPEP, AeroEclipse), directly competing with Dymedso in the respiratory therapy device category for patients with chronic lung conditions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dymedso